Annual EBITDA
-$136.49 M
-$13.64 M-11.10%
31 December 2023
Summary:
Mirum Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$136.49 million, with the most recent change of -$13.64 million (-11.10%) on 31 December 2023. During the last 3 years, it has fallen by -$70.72 million (-107.54%). MIRM annual EBITDA is now -161.44% below its all-time high of -$52.21 million, reached on 31 December 2019.MIRM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.25 M
+$10.33 M+70.87%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.25 million, with the most recent change of +$10.33 million (+70.87%) on 30 September 2024. Over the past year, it has increased by +$22.13 million (+83.90%). MIRM quarterly EBITDA is now -106.92% below its all-time high of $61.38 million, reached on 31 December 2021.MIRM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$60.62 M
+$12.86 M+17.50%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$60.62 million, with the most recent change of +$12.86 million (+17.50%) on 30 September 2024. Over the past year, it has increased by +$75.87 million (+55.59%). MIRM TTM EBITDA is now -93158.46% below its all-time high of -$65.00 thousand, reached on 30 September 2018.MIRM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +83.9% | +55.6% |
| 3 y3 years | -107.5% | -106.9% | +7.8% |
| 5 y5 years | -161.4% | +74.0% | -16.1% |
MIRM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -107.5% | at low | -106.9% | +93.8% | -97.2% | +60.7% |
| 5 y | 5 years | -161.4% | at low | -106.9% | +93.8% | -97.2% | +63.0% |
| alltime | all time | -161.4% | at low | -106.9% | +93.8% | <-9999.0% | +63.0% |
Mirum Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.25 M(-70.9%) | -$60.62 M(-17.5%) |
| June 2024 | - | -$14.58 M(-5.4%) | -$73.47 M(-42.4%) |
| Mar 2024 | - | -$15.41 M(-41.6%) | -$127.55 M(-6.5%) |
| Dec 2023 | -$136.49 M(+11.1%) | -$26.38 M(+54.2%) | -$136.49 M(-3.1%) |
| Sept 2023 | - | -$17.10 M(-75.1%) | -$140.84 M(-8.8%) |
| June 2023 | - | -$68.66 M(+182.0%) | -$154.37 M(+34.4%) |
| Mar 2023 | - | -$24.35 M(-20.8%) | -$114.83 M(-6.5%) |
| Dec 2022 | -$122.85 M(+86.8%) | -$30.73 M(+0.3%) | -$122.85 M(+299.6%) |
| Sept 2022 | - | -$30.63 M(+5.2%) | -$30.74 M(-25.7%) |
| June 2022 | - | -$29.12 M(-10.1%) | -$41.37 M(-19.2%) |
| Mar 2022 | - | -$32.38 M(-152.7%) | -$51.18 M(-22.2%) |
| Dec 2021 | -$65.77 M | $61.38 M(-248.8%) | -$65.77 M(-59.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$41.25 M(+6.0%) | -$163.85 M(+13.8%) |
| June 2021 | - | -$38.93 M(-17.1%) | -$143.95 M(+12.4%) |
| Mar 2021 | - | -$46.96 M(+28.0%) | -$128.12 M(+25.2%) |
| Dec 2020 | -$102.31 M(+96.0%) | -$36.70 M(+71.9%) | -$102.31 M(+24.9%) |
| Sept 2020 | - | -$21.35 M(-7.6%) | -$81.93 M(+7.3%) |
| June 2020 | - | -$23.10 M(+9.2%) | -$76.36 M(+13.6%) |
| Mar 2020 | - | -$21.15 M(+29.5%) | -$67.20 M(+28.7%) |
| Dec 2019 | -$52.21 M | -$16.33 M(+3.5%) | -$52.21 M(+45.5%) |
| Sept 2019 | - | -$15.78 M(+13.1%) | -$35.88 M(+77.9%) |
| June 2019 | - | -$13.95 M(+126.5%) | -$20.17 M(+224.1%) |
| Mar 2019 | - | -$6.16 M(+9372.3%) | -$6.22 M(+9472.3%) |
| Sept 2018 | - | -$65.00 K | -$65.00 K |
FAQ
- What is Mirum Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Mirum Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM EBITDA year-on-year change?
What is Mirum Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MIRM is -$136.49 M
What is the all time high annual EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$52.21 M
What is Mirum Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MIRM is -$4.25 M
What is the all time high quarterly EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $61.38 M
What is Mirum Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, MIRM quarterly earnings before interest, taxes, depreciation & amortization has changed by +$22.13 M (+83.90%)
What is Mirum Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MIRM is -$60.62 M
What is the all time high TTM EBITDA for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$65.00 K
What is Mirum Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, MIRM TTM earnings before interest, taxes, depreciation & amortization has changed by +$75.87 M (+55.59%)